Investing
Top 10 Analyst Upgrades & Downgrades (AMGN, COP, DD, GENZ, GS, MON, MOS, BBY, PBR, VMW)
Published:
Last Updated:
These are ten of the top impact research calls with upgrades and downgrades from Wall Street early this Friday morning:
Amgen (AMGN) Raised to Overweight at JPMorgan.
ConocoPhillips (COP) Raised to Buy at Goldman Sachs.
DuPont (DD) Started as Buy at UBS.
Genzyme (GENZ) Started as Buy at Piper Jaffray.
Goldman Sachs (GS) Started as Outperform at FBR.
Monsanto (MON) Started as Buy at UBS.
Mosaic (MOS) Started as Buy at UBS.
Best Buy (BBY) Removed from Goldman Sachs Conviction Buy List, but maintained as “Buy.”
Petrobras (PBR) Cut to Hold at Deutsche Bank.
VMware (VMW) Cut to Sell at Auriga.
JON C. OGG
March 27, 2009
Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance—and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor.
Here’s how it works:
Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.